PapersPMID:39854533
Effects of Cinnamomum zeylanicum (Ceylon cinnamon) extract on lipid profile, glucose levels and its safety in adults: A randomized, double-blind, controlled trial.
No finding here moved its endpoint.
What did not
1 findingHow to read these marks →“Of the 127 participants with a 12 week assessment, those in the C. zeylanicum arm had a lower LDL-C value than the placebo arm but the difference was not significant (the baseline adjusted mean difference was 6.05 mg/dL; 95% CI: -2.43 to 14.52; p = 0.161; Table 2).”
- Study
- RCT
- Participants
- 127
- Duration
- 3 months
- Effect
- 6.05 mean difference, 95% CI −2.43 to 14.52
- Interests
- Industry funded
- Dose studied
- two 500 mg capsules per day (1000 mg/day), one before breakfast and one before dinner, for 12 weeks
- Population
- Sri Lankan adults aged 18 to 70 with LDL-C between 100 and 190 mg/dL, not on statins or other lipid-lowering drugs
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- adults aged 18 to 70 years with LDL-C between 100 and 190 mg/dL, Sri Lanka
- Participants
- 150
- Comparator
- placebo
- Duration
- 84 days
- Endpoints measured
- 38